Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Nephrolithiasis (Page 6)

873 drugs have been associated with Nephrolithiasis in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
ERLOTINIB 41 2 26 0
HUMAN C1-ESTERASE INHIBITOR 41 0 22 1
PHENTERMINE\TOPIRAMATE 41 0 10 0
LEVONORGESTREL 40 0 14 1
AMOXICILLIN 39 1 31 2
BOSENTAN 39 0 24 0
CHOLECALCIFEROL 39 0 12 1
CORTICOTROPIN 39 2 16 0
IXAZOMIB 39 1 31 1
LAMOTRIGINE 39 0 11 2
PEMBROLIZUMAB 39 4 25 2
BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE 38 0 12 0
BUPRENORPHINE\NALOXONE 38 1 17 0
MOMETASONE FUROATE 38 0 26 11
OSIMERTINIB 38 1 17 0
TADALAFIL 38 0 17 0
AVAPRITINIB 37 0 15 0
LIDOCAINE 37 0 30 0
NIVOLUMAB 37 3 15 0
POTASSIUM 37 0 15 0
ATENOLOL 36 0 12 1
SELEXIPAG 36 3 23 0
TRIAMCINOLONE 36 0 0 0
BISOPROLOL 35 0 33 0
BUPROPION\NALTREXONE 35 0 12 0
FOSAMAX 35 3 34 0
TOZINAMERAN 35 0 10 2
TRASTUZUMAB 35 0 22 0
CANDESARTAN 34 0 3 0
CLARITHROMYCIN 34 0 5 1
INDOMETHACIN 34 0 30 0
MONTELUKAST 34 0 20 0
SOFOSBUVIR\VELPATASVIR 34 0 12 0
ZOLMITRIPTAN 34 0 3 0
DICLOFENAC DIETHYLAMINE 33 0 3 0
DROXIDOPA 33 0 16 1
RAVULIZUMAB-CWVZ 33 1 11 0
ACETAMINOPHEN\DIPHENHYDRAMINE 32 0 18 0
AREDIA 32 14 28 0
CANDESARTAN CILEXETIL 32 0 8 3
DASATINIB 32 1 17 0
DEFLAZACORT 32 0 11 0
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN 32 2 7 0
SARILUMAB 32 0 14 0
ALENDRONATE\CHOLECALCIFEROL 31 0 27 0
ANAKINRA 31 0 13 0
CLOZAPINE 31 1 27 2
DABRAFENIB 31 3 10 0
DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR 31 0 16 0
TOLVAPTAN 31 0 12 0
« 1 … 3 4 5 6 7 8 9 … 18 »